Drug intelligence / Profile preview

Bone marrow aspirate concentrate

Development stage
Unknown
Lead developer
Terumo BCT
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intramyocardial
01

Overview

Bone marrow aspirate concentrate (BMAC) is an autologous cell therapy produced by concentrating a patient's own bone marrow aspirate using a point-of-care centrifugation system, such as the Harvest BMAC System developed by Harvest Technologies (now part of Terumo BCT). The resulting concentrate contains a heterogeneous population of nucleated cells, including mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), and endothelial progenitor cells (EPCs), along with a concentrated mix of cytokines and growth factors. In the treatment of ischemic congestive heart failure, BMAC is typically administered via intramyocardial injection during coronary artery bypass grafting (CABG) surgery. The therapeutic effect is primarily mediated through paracrine mechanisms; the injected cells secrete various factors that promote angiogenesis, modulate the inflammatory response, and reduce apoptosis of cardiomyocytes, thereby improving myocardial perfusion and ventricular function.

Brand names
Harvest BMAC
Other names
Autologous concentrated bone marrow nucleated cellsBMMNCBone marrow mononuclear cellsAutologous bone marrow-derived mononuclear cells

Beyond the preview

Go deeper on Bone marrow aspirate concentrate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bone marrow aspirate concentrate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call